BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31270884)

  • 1. Knockdown of Notch1 inhibits nasopharyngeal carcinoma cell growth and metastasis via downregulation of CCL2, CXCL16, and uPA.
    Guo H; Wang F; Diao Y; Zhang Z; Chen Q; Qian CN; Keller ET; Zhang J; Lu Y
    Mol Carcinog; 2019 Oct; 58(10):1886-1896. PubMed ID: 31270884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEK inhibitor diminishes nasopharyngeal carcinoma (NPC) cell growth and NPC-induced osteoclastogenesis via modulating CCL2 and CXCL16 expressions.
    Zhu Y; Zou C; Zhang Z; Qian CN; Yang X; Shi J; Xia Y; Zhang J; Lu Y
    Tumour Biol; 2015 Nov; 36(11):8811-8. PubMed ID: 26058873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of lncRNA SNHG12 predicts a poor prognosis of nasopharyngeal carcinoma and regulates cell proliferation and metastasis by modulating Notch signal pathway.
    Liu ZB; Tang C; Jin X; Liu SH; Pi W
    Cancer Biomark; 2018; 23(4):603-613. PubMed ID: 30452404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
    Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. URG4-silencing suppresses cell proliferation in nasopharyngeal carcinoma through induction of apoptosis.
    Luo XY; Yan B; Cai CF; Chen AM; Zhou M
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1717-1725. PubMed ID: 29630117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 inactivation promotes invasion and metastasis of nasopharyngeal carcinoma cells partly through Slug activation.
    An JS; Rho YS; Moon JH; Lim YC
    Neoplasma; 2020 Mar; 67(2):259-266. PubMed ID: 31777263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
    Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
    Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
    Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator.
    Bin Hafeez B; Adhami VM; Asim M; Siddiqui IA; Bhat KM; Zhong W; Saleem M; Din M; Setaluri V; Mukhtar H
    Clin Cancer Res; 2009 Jan; 15(2):452-9. PubMed ID: 19147749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
    Wu Q; Han T; Sheng X; Zhang N; Wang P
    Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM24 siRNA induced cell apoptosis and reduced cell viability in human nasopharyngeal carcinoma cells.
    Wang P; Shen N; Liu D; Ning X; Wu D; Huang X
    Mol Med Rep; 2018 Jul; 18(1):369-376. PubMed ID: 29749443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
    Qian W; Ren Z; Lu X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.
    Bao YN; Cao X; Luo DH; Sun R; Peng LX; Wang L; Yan YP; Zheng LS; Xie P; Cao Y; Liang YY; Zheng FJ; Huang BJ; Xiang YQ; Lv X; Chen QY; Chen MY; Huang PY; Guo L; Mai HQ; Guo X; Zeng YX; Qian CN
    Cell Cycle; 2014; 13(12):1958-69. PubMed ID: 24763226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placenta specific 8 gene induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via the TGF-β/Smad pathway.
    Huang ML; Zou Y; Yang R; Jiang Y; Sheng JF; Han JB; Kong YG; Tao ZZ; Chen SM
    Exp Cell Res; 2019 Jan; 374(1):172-180. PubMed ID: 30496758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
    Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
    Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
    Mu Y; Zou H; Chen B; Fan Y; Luo S
    Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the Numb/Notch signaling pathway increases radiation sensitivity in human nasopharyngeal carcinoma cells.
    Shen ED; Zeng Q
    Kaohsiung J Med Sci; 2019 Aug; 35(8):474-485. PubMed ID: 31271505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-299 targets VEGFA and inhibits the growth, chemosensitivity and invasion of human nasopharyngeal carcinoma cells.
    Chen J; Lu F; Hu C
    J BUON; 2019; 24(5):2049-2055. PubMed ID: 31786874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOTCH1 signaling contributes to cell growth, anti-apoptosis and metastasis in salivary adenoid cystic carcinoma.
    Su BH; Qu J; Song M; Huang XY; Hu XM; Xie J; Zhao Y; Ding LC; She L; Chen J; Lin LS; Lin X; Zheng DL; Lu YG
    Oncotarget; 2014 Aug; 5(16):6885-95. PubMed ID: 25149541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.